Adiponectin and smoking status: A systematic review

Journal of Atherosclerosis and Thrombosis

Volumn 19, Issue 9, 2012, Pages 787-794

  Kotani, Kazuhiko ^a   Hazama, Ayako ^b   Hagimoto, Akiko ^c   Saika, Kumiko ^d   Shigeta, Masako ^e   Katanoda, Kota ^d   Nakamura, Masakazu ^f  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c FUJITA HEALTH UNIVERSITY   (Japan)

^d NATIONAL CANCER CENTER   (Japan)

^e KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^f Osaka Center for Cancer and Cardiovascular Diseases Prevention   (Japan)

Author keywords

Adipocytokine; Lifestyle; Nicotine; Tobacco

Indexed keywords

ADIPONECTIN; AMFEBUTAMONE;

CASE CONTROL STUDY; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; HUMAN; INTERVENTION STUDY; REVIEW; SMOKING CESSATION; SYSTEMATIC REVIEW; TOBACCO DEPENDENCE; TREATMENT DURATION;

ADIPONECTIN; ADULT; FEMALE; HUMANS; MALE; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 84867911093     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.11833     Document Type: Review

References (36)

1. Ueshima H: Explanation for the Japanese paradox: prevention of increase in coronary heart disease and reduction in stroke. J Atheroscler Thromb, 2007; 14: 278-286
2. Wipfli H, Samet JM: Global economic and health benefits of tobacco control: part 1. Clin Pharmacol Ther, 2009; 86: 263-271
3. Wipfli H, Samet JM: Global economic and health benefits of tobacco control: part 2. Clin Pharmacol Ther, 2009; 86: 272-280
4. Pan WH, Yeh WT, Weng LC: Epidemiology of metabolic syndrome in Asia. Asia Pac J Clin Nutr, 2008; 17: S37-42
5. Kohro T, Furui Y, Mitsutake N, Fujii R, Morita H, Oku S, Ohe K, Nagai R: The Japanese national health screening and intervention program aimed at preventing worsening of the metabolic syndrome. Int Heart J, 2008; 49: 193-203
6. Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, Yamakado M: Association between cigarette smoking, metabolic syndrome and carotid arteriosclerosis in Japanese individuals. Atherosclerosis, 2005; 181: 381-388
7. Nakanishi N, Takatorige T, Suzuki K: Cigarette smoking and the risk of the metabolic syndrome in middle-aged Japanese male office workers. Ind Health, 2005; 43: 295-301
8. Miyatake N, Wada J, Kawasaki Y, Nishii K, Makino H, Numata T: Relationship between metabolic syndrome and cigarette smoking in the Japanese population. Intern Med, 2006; 45: 1039-1043
9. Wilsgaard T, Jacobsen BK: Lifestyle factors and incident metabolic syndrome. The Tromsø Study 1979-2001. Diabetes Res Clin Pract, 2007; 78: 217-224
10. Maury E, Brichard SM: Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol, 2010; 314: 1-16
11. Kawano J, Arora R: The role of adiponectin in obesity, diabetes, and cardiovascular disease. J Cardiometab Syndr, 2009; 4: 44-49
12. Matsuzawa Y: Adiponectin; a key player in obesity related disorders. Curr Pharm Des, 2010; 16: 1896-1901
13. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, Atkins D; Methods Work Group, Third US Preventive Services Task Force: Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med, 2001; 20: S21-35
14. Kawamoto R, Tabara Y, Kohara K, Miki T, Ohtsuka N, Kusunoki T, Abe M: Smoking status is associated with serum high molecular adiponectin levels in communitydwelling Japanese men. J Atheroscler Thromb, 2010; 17: 423-430
15. Efstathiou SP, Skeva II, Dimas C, Panagiotou A, Parisi K, Tzanoumis L, Kafouri A, Bakratsas K, Mountokalakis TD: Smoking cessation increases serum adiponectin levels in an apparently healthy Greek population. Atherosclerosis, 2009; 205: 632-636
16. Otsuka F, Kojima S, Maruyoshi H, Kojima S, Matsuzawa Y, Funahashi T, Kaikita K, Sugiyama S, Kimura K, Umemura S, Ogawa H: Smoking cessation is associated with increased plasma adiponectin levels in men. J Cardiol, 2009; 53: 219-225
17. Sull JW, Kim HJ, Yun JE, Park EJ, Kim G, Jee SH: Serum adiponectin is associated with smoking status in healthy Korean men. Endocr J, 2009; 56: 73-78
18. Ahonen TM, Kautiainen HJ, Keinänen-Kiukaanniemi SM, Kumpusalo EA, Vanhala MJ: Gender difference among smoking, adiponectin, and high-sensitivity C-reactive protein. Am J Prev Med, 2008; 35: 598-601
19. Jang Y, Koh SJ, Kim OY, Kim BK, Choi D, Hyun YJ, Kim HJ, Chae JS, Lee JH: Effect of the 252A>G polymorphism of the lymphotoxin-alpha gene on inflammatory markers of response to cigarette smoking in Korean healthy men. Clin Chim Acta, 2007; 377: 221-227
20. Takefuji S, Yatsuya H, Tamakoshi K, Otsuka R, Wada K, Matsushita K, Sugiura K, Hotta Y, Mitsuhashi H, Oiso Y, Toyoshima H: Smoking status and adiponectin in healthy Japanese men and women. Prev Med, 2007; 45: 471-475
21. Abbasi F, Farin HM, Lamendola C, McLaughlin T, Schwartz EA, Reaven GM, Reaven PD: The relationship between plasma adiponectin concentration and insulin resistance is altered in smokers. J Clin Endocrinol Metab, 2006; 91: 5002-5007
22. Kim OY, Koh SJ, Jang Y, Chae JS, Kim JY, Kim HJ, Cho H, Lee JH: Plasma adiponectin is related to other cardiovascular risk factors in nondiabetic Korean men with CAD, independent of adiposity and cigarette smoking: cross-sectional analysis. Clin Chim Acta, 2006; 370: 63-71
23. Iwashima Y, Katsuya T, Ishikawa K, Kida I, Ohishi M, Horio T, Ouchi N, Ohashi K, Kihara S, Funahashi T, Rakugi H, Ogihara T: Association of hypoadiponectinemia with smoking habit in men. Hypertension, 2005; 45: 1094-1100
24. Tsukinoki R, Morimoto K, Nakayama K: Association between lifestyle factors and plasma adiponectin levels in Japanese men. Lipids Health Dis, 2005; 4: 27
25. Hirose H, Yamamoto Y, Seino-Yoshihara Y, Kawabe H, Saito I: Serum high-molecular-weight adiponectin as a marker for the evaluation and care of subjects with metabolic syndrome and related disorders. J Atheroscler Thromb, 2010; 17: 1201-1211
26. Havel PJ: Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes, 2004; 53: S143-151
27. You T, Nicklas BJ: Effects of exercise on adipokines and the metabolic syndrome. Curr Diab Rep, 2008; 8: 7-11
28. Kawamoto R, Tabara Y, Kohara K, Miki T, Ohtsuka N, Kusunoki T, Abe M: Alcohol drinking status is associated with serum high molecular weight adiponectin in community-dwelling Japanese men. J Atheroscler Thromb, 2010; 17: 953-962
29. Isobe T, Saitoh S, Takagi S, Takeuchi H, Chiba Y, Katoh N, Shimamoto K: Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study. Eur J Endocrinol, 2005; 153: 91-98
30. Adamczak M, Rzepka E, Chudek J, Wiecek A: Ageing and plasma adiponectin concentration in apparently healthy males and females. Clin Endocrinol, 2005; 62: 114-118
31. Andersson K, Arner P: Systemic nicotine stimulates human adipose tissue lipolysis through local cholinergic and catecholaminergic receptors. Int J Obes Relat Metab Disord, 2001; 25: 1225-1232
32. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G: Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes, 2003; 52: 1779-1785
33. Okamoto Y, Arita Y, Nishida M, Muraguchi M, Ouchi N, Takahashi M, Igura T, Inui Y, Kihara S, Nakamura T, Yamashita S, Miyagawa J, Funahashi T, Matsuzawa Y: An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res, 2000; 32: 47-50
34. Fagard RH, Nilsson PM: Smoking and diabetes-the double health hazard! Prim Care Diabetes, 2009; 3: 205-209
35. Tonstad S: Cigarette smoking, smoking cessation, and diabetes. Diabetes Res Clin Pract, 2009; 85: 4-13
36. Audrain-McGovern J, Benowitz NL: Cigarette smoking, nicotine, and body weight. Clin Pharmacol Ther, 2011; 90: 164-168